Trends in first-line antiretroviral therapy in Asia: Results from the treat Asia HIV Observational Database

10.1371/journal.pone.0106525

Saved in:
Bibliographic Details
Main Authors: Boettiger D.C., Kerr S., Ditangco R., Merati T.P., Pham T.T.T., Chaiwarith R., Kiertiburanakul S., Li C.K.P., Kumarasamy N., Vonthanak S., Lee C., Van Kinh N., Pujari S., Wong W.W., Kamarulzaman A., Zhang F., Yunihastuti E., Choi J.Y., Oka S., Ng O.T., Kantipong P., Mustafa M., Ratanasuwan W., Sohn A., Law M.
Other Authors: SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Format: Article
Published: 2019
Subjects:
HIV
Online Access:https://scholarbank.nus.edu.sg/handle/10635/161774
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-161774
record_format dspace
spelling sg-nus-scholar.10635-1617742023-10-31T08:35:17Z Trends in first-line antiretroviral therapy in Asia: Results from the treat Asia HIV Observational Database Boettiger D.C. Kerr S. Ditangco R. Merati T.P. Pham T.T.T. Chaiwarith R. Kiertiburanakul S. Li C.K.P. Kumarasamy N. Vonthanak S. Lee C. Van Kinh N. Pujari S. Wong W.W. Kamarulzaman A. Zhang F. Yunihastuti E. Choi J.Y. Oka S. Ng O.T. Kantipong P. Mustafa M. Ratanasuwan W. Sohn A. Law M. SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH abacavir atazanavir darunavir didanosine efavirenz emtricitabine fosamprenavir Human immunodeficiency virus proteinase inhibitor indinavir lamivudine lopinavir nelfinavir nevirapine nonnucleoside reverse transcriptase inhibitor raltegravir rilpivirine RNA directed DNA polymerase inhibitor saquinavir stavudine tenofovir tipranavir zalcitabine zidovudine 2',3' dideoxynucleoside derivative abacavir anti human immunodeficiency virus agent RNA directed DNA polymerase inhibitor stavudine adult aging antiretroviral therapy antiviral therapy Article Asia data base drug safety drug use drug utilization female hepatitis C human Human immunodeficiency virus infection major clinical study male observational study prescription primary health care risk factor sex difference treatment failure trend study adverse drug reaction adverse effects classification drug effects highly active antiretroviral therapy HIV Infections Human immunodeficiency virus pathology procedures virology Adult Anti-HIV Agents Antiretroviral Therapy, Highly Active Asia Dideoxynucleosides Drug-Related Side Effects and Adverse Reactions Female HIV HIV Infections Humans Male Nevirapine Reverse Transcriptase Inhibitors Stavudine 10.1371/journal.pone.0106525 PLoS ONE 9 9 e106525 2019-11-07T05:07:49Z 2019-11-07T05:07:49Z 2014 Article Boettiger D.C., Kerr S., Ditangco R., Merati T.P., Pham T.T.T., Chaiwarith R., Kiertiburanakul S., Li C.K.P., Kumarasamy N., Vonthanak S., Lee C., Van Kinh N., Pujari S., Wong W.W., Kamarulzaman A., Zhang F., Yunihastuti E., Choi J.Y., Oka S., Ng O.T., Kantipong P., Mustafa M., Ratanasuwan W., Sohn A., Law M. (2014). Trends in first-line antiretroviral therapy in Asia: Results from the treat Asia HIV Observational Database. PLoS ONE 9 (9) : e106525. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0106525 19326203 https://scholarbank.nus.edu.sg/handle/10635/161774 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20191101
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic abacavir
atazanavir
darunavir
didanosine
efavirenz
emtricitabine
fosamprenavir
Human immunodeficiency virus proteinase inhibitor
indinavir
lamivudine
lopinavir
nelfinavir
nevirapine
nonnucleoside reverse transcriptase inhibitor
raltegravir
rilpivirine
RNA directed DNA polymerase inhibitor
saquinavir
stavudine
tenofovir
tipranavir
zalcitabine
zidovudine
2',3' dideoxynucleoside derivative
abacavir
anti human immunodeficiency virus agent
RNA directed DNA polymerase inhibitor
stavudine
adult
aging
antiretroviral therapy
antiviral therapy
Article
Asia
data base
drug safety
drug use
drug utilization
female
hepatitis C
human
Human immunodeficiency virus infection
major clinical study
male
observational study
prescription
primary health care
risk factor
sex difference
treatment failure
trend study
adverse drug reaction
adverse effects
classification
drug effects
highly active antiretroviral therapy
HIV Infections
Human immunodeficiency virus
pathology
procedures
virology
Adult
Anti-HIV Agents
Antiretroviral Therapy, Highly Active
Asia
Dideoxynucleosides
Drug-Related Side Effects and Adverse Reactions
Female
HIV
HIV Infections
Humans
Male
Nevirapine
Reverse Transcriptase Inhibitors
Stavudine
spellingShingle abacavir
atazanavir
darunavir
didanosine
efavirenz
emtricitabine
fosamprenavir
Human immunodeficiency virus proteinase inhibitor
indinavir
lamivudine
lopinavir
nelfinavir
nevirapine
nonnucleoside reverse transcriptase inhibitor
raltegravir
rilpivirine
RNA directed DNA polymerase inhibitor
saquinavir
stavudine
tenofovir
tipranavir
zalcitabine
zidovudine
2',3' dideoxynucleoside derivative
abacavir
anti human immunodeficiency virus agent
RNA directed DNA polymerase inhibitor
stavudine
adult
aging
antiretroviral therapy
antiviral therapy
Article
Asia
data base
drug safety
drug use
drug utilization
female
hepatitis C
human
Human immunodeficiency virus infection
major clinical study
male
observational study
prescription
primary health care
risk factor
sex difference
treatment failure
trend study
adverse drug reaction
adverse effects
classification
drug effects
highly active antiretroviral therapy
HIV Infections
Human immunodeficiency virus
pathology
procedures
virology
Adult
Anti-HIV Agents
Antiretroviral Therapy, Highly Active
Asia
Dideoxynucleosides
Drug-Related Side Effects and Adverse Reactions
Female
HIV
HIV Infections
Humans
Male
Nevirapine
Reverse Transcriptase Inhibitors
Stavudine
Boettiger D.C.
Kerr S.
Ditangco R.
Merati T.P.
Pham T.T.T.
Chaiwarith R.
Kiertiburanakul S.
Li C.K.P.
Kumarasamy N.
Vonthanak S.
Lee C.
Van Kinh N.
Pujari S.
Wong W.W.
Kamarulzaman A.
Zhang F.
Yunihastuti E.
Choi J.Y.
Oka S.
Ng O.T.
Kantipong P.
Mustafa M.
Ratanasuwan W.
Sohn A.
Law M.
Trends in first-line antiretroviral therapy in Asia: Results from the treat Asia HIV Observational Database
description 10.1371/journal.pone.0106525
author2 SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
author_facet SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Boettiger D.C.
Kerr S.
Ditangco R.
Merati T.P.
Pham T.T.T.
Chaiwarith R.
Kiertiburanakul S.
Li C.K.P.
Kumarasamy N.
Vonthanak S.
Lee C.
Van Kinh N.
Pujari S.
Wong W.W.
Kamarulzaman A.
Zhang F.
Yunihastuti E.
Choi J.Y.
Oka S.
Ng O.T.
Kantipong P.
Mustafa M.
Ratanasuwan W.
Sohn A.
Law M.
format Article
author Boettiger D.C.
Kerr S.
Ditangco R.
Merati T.P.
Pham T.T.T.
Chaiwarith R.
Kiertiburanakul S.
Li C.K.P.
Kumarasamy N.
Vonthanak S.
Lee C.
Van Kinh N.
Pujari S.
Wong W.W.
Kamarulzaman A.
Zhang F.
Yunihastuti E.
Choi J.Y.
Oka S.
Ng O.T.
Kantipong P.
Mustafa M.
Ratanasuwan W.
Sohn A.
Law M.
author_sort Boettiger D.C.
title Trends in first-line antiretroviral therapy in Asia: Results from the treat Asia HIV Observational Database
title_short Trends in first-line antiretroviral therapy in Asia: Results from the treat Asia HIV Observational Database
title_full Trends in first-line antiretroviral therapy in Asia: Results from the treat Asia HIV Observational Database
title_fullStr Trends in first-line antiretroviral therapy in Asia: Results from the treat Asia HIV Observational Database
title_full_unstemmed Trends in first-line antiretroviral therapy in Asia: Results from the treat Asia HIV Observational Database
title_sort trends in first-line antiretroviral therapy in asia: results from the treat asia hiv observational database
publishDate 2019
url https://scholarbank.nus.edu.sg/handle/10635/161774
_version_ 1781791835421671424